ProPhase Labs (PRPH) News Today $0.33 +0.01 (+2.21%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRPH Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call TranscriptMay 20 at 8:02 PM | seekingalpha.comProPhase Labs Q1 2025 Earnings PreviewMay 20 at 12:54 AM | msn.comProPhase Labs's Earnings OutlookMay 20 at 12:54 AM | benzinga.comFinancial Review: ProPhase Labs (NASDAQ:PRPH) versus Vectura Group (OTCMKTS:VEGPF)May 19 at 1:49 AM | americanbankingnews.comProPhase Labs Delays Form 10-Q FilingMay 16, 2025 | tipranks.comProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025May 13, 2025 | globenewswire.comCovid Test Lab Weighs Unusual Debt-Collection Plan: BankruptcyMay 13, 2025 | wsj.comProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024April 2, 2025 | seekingalpha.comProPhase Labs reports FY24 EPS ($2.61) vs (98c) last yearApril 1, 2025 | markets.businessinsider.comProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024March 31, 2025 | globenewswire.comProPhase Labs FY 2024 Earnings PreviewMarch 28, 2025 | msn.com6PRPH : An Overview of ProPhase Labs's EarningsMarch 28, 2025 | benzinga.comProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025March 27, 2025 | globenewswire.comProPhase Labs to Present at the Investor Summit Virtual on March 11March 7, 2025 | globenewswire.comDiamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)February 26, 2025 | globenewswire.comProPhase Labs examines opportunities to leverage DTC multi-media infrastructureFebruary 25, 2025 | markets.businessinsider.comProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription DrugsFebruary 25, 2025 | globenewswire.comProPhase Labs provides update on cash generation initiativesFebruary 20, 2025 | markets.businessinsider.comProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 ReceivablesFebruary 20, 2025 | globenewswire.comProPhase Labs hires Stuart Hollenshead as COOFebruary 19, 2025 | markets.businessinsider.comProPhase Labs hires former Barstool Sports COO Stuart Hollenshead, plans cost-cutting measuresFebruary 19, 2025 | msn.comProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool SportsFebruary 18, 2025 | globenewswire.comProPhase Labs stock hits 52-week low at $0.41 amid sharp declineJanuary 31, 2025 | msn.comProPhase Labs closes $23.6M sale of Pharmaloz ManufacturingJanuary 22, 2025 | markets.businessinsider.comProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity FirmJanuary 22, 2025 | markets.businessinsider.comProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market StrugglesJanuary 22, 2025 | msn.comProPhase Labs finalizing set of cost-saving measures for non-core operationsDecember 12, 2024 | markets.businessinsider.comProPhase Labs secures private equity backing, nears lozenge dealDecember 12, 2024 | markets.businessinsider.comProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call TranscriptNovember 15, 2024 | seekingalpha.comProPhase Labs: Strategic Moves for Future GrowthNovember 14, 2024 | markets.businessinsider.comProPhase Labs Announces Closing of Public Offering of Common StockNovember 13, 2024 | markets.businessinsider.comProPhase Labs Announces Proposed Public Offering of Common StockNovember 11, 2024 | theglobeandmail.comProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024November 11, 2024 | globenewswire.comProPhase Labs announces common stock offering, no amount givenNovember 9, 2024 | markets.businessinsider.comProPhase Labs 4.17M share Spot Secondary priced at $.72November 8, 2024 | markets.businessinsider.comProPhase Labs Announces Pricing of Public Offering of Common StockNovember 7, 2024 | globenewswire.comProPhase Labs Launches DNA Complete®: Transforming Direct-to-Consumer Genetic Testing for Health, Wellness, and Enhanced AncestryNovember 4, 2024 | markets.businessinsider.comProPhase Labs (NASDAQ:PRPH) Stock, Short Interest ReportOctober 28, 2024 | benzinga.comProPhase Labs to Present at the 2024 ThinkEquity ConferenceOctober 22, 2024 | markets.businessinsider.comProPhase Labs, Inc.: ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025October 17, 2024 | finanznachrichten.deProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025October 17, 2024 | globenewswire.comProPhase Labs (NASDAQ:PRPH) Stock, Insider Trading ActivityOctober 9, 2024 | benzinga.comProPhase Labs announces change in accounting firmOctober 6, 2024 | uk.investing.comDiamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)August 27, 2024 | globenewswire.comProPhase Labs secures $10M in amended note agreementAugust 24, 2024 | uk.investing.comProPhase Labs to Present at August 20th Virtual Investor Summit Microcap EventAugust 19, 2024 | globenewswire.comProPhase Labs, Inc. (NASDAQ:PRPH) Q2 2024 Earnings Call TranscriptAugust 15, 2024 | msn.com Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address PRPH Media Mentions By Week PRPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRPH News Sentiment▼0.330.65▲Average Medical News Sentiment PRPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRPH Articles This Week▼51▲PRPH Articles Average Week Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KPTI News Today RENB News Today ARTV News Today OTLK News Today VNRX News Today PEPG News Today ATNM News Today STTK News Today ICCC News Today VRCA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRPH) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProPhase Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProPhase Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.